Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis

Journal of Viral Hepatitis

Volumn 5, Issue 3, 1998, Pages 153-159

  Tanaka, E ^a   Kiyosawa, K ^a   Shimoda, K ^b   Hino, K ^c   Tacke, M ^d   Schmolke, S ^d   Engel, A M ^d   Hess, G ^d  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kisaragi Institute for Liver Research   (Japan)

^c Hepatitis Research Institute   (Japan)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Acute hepatitis; Antibody to envelope 2 protein; Hepatitis C virus; Hepatitis G virus; Transfusion associated hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS HEPATITIS; VIRUS INFECTION;

ACUTE DISEASE; ADULT; ANTIGENS, VIRAL; BLOOD TRANSFUSION; FEMALE; FLAVIVIRIDAE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RNA, VIRAL; VIRAL ENVELOPE PROTEINS;

EID: 0031858480     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.00095.x     Document Type: Article

References (30)

1. Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-1500.
2. Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N Engl J Med 1991; 325: 1325-1329.
3. Tanaka E, Kiyosawa K, Nakatsuji Y et al. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up. J Med Virol 1993; 39: 318-324.
4. Alter HJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 1995; 15: 110-120.
5. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis virus. Nature Med 1995; 1: 564-569.
6. Linnen J, Wages J Jr, Zhang-Keck Z-Y et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-508.
7. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334: 1536-1537.
8. Tacke M, Kiyosawa K, Stark K et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-320.
9. Pilot-Matias TJ, Carrick RJ, Coleman PF et al. Expression of the GB virus C E2 glycoprotein using the semlik forest virus vector system and its utility as a serologic marker. Virology 1996; 225: 282-292.
10. Dille BJ, Surowy TK, Gutierrez RA et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1996; 225: 293-299.
11. Wang JT, Tsai FC, Lee CZ et al. A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C. Blood 1996; 88: 1881-1886.
12. Alter MJ, Gallagher M, Morris TT et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741-746.
13. Alter HJ, Nakatsuji Y, Melpolder J et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.
14. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-α2a therapy in patients with chronic hepatitis C. Dig Dis Sci 1994; 39: 1273-1280.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
16. Tanaka E, Yamaguchi K, Uemura K et al. Hepatitis G virus/GB virus C infection in patients with chronic non-B. non-C hepatitis. Int Hepatol Commun 1997; 6: 137-143.
17. Kato N, Ootsuyama Y, Tanaka T et al. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992; 22: 107-123.
18. Weiner AJ, Brauer MJ, Rosenblatt J et al. Variable and hypervariable domains are found in the region of HCV corresponding to the Flavivirus envelope and NS1 proteins and the Pestivirus envelope glycoproteins. Virology 1991; 180: 842-848.
19. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468-3472.
20. Kato N, Sekiya H, Ootsuyama Y et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923-3930.
21. Shimizu Y, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994; 68: 1494-1500.
22. Hijikata M, Mishiro S. Circulating immune complexes that contain HCV but not GBV-C in co-infected hosts. Intern Hepatol Commun 1996; 5: 339-344.
23. Takahashi K, Hijikata M, Aoyama K, Hoshino H, Hino K, Mishiro S. Characterization of GBV-C/HGV viral genome: comparison among different isolates for a 2 kb sequence that covers entire E1 and most of 5′UTR and E2. Int Hepatol Commun 1997; 6: 253-263.
24. Carman WF. Vaccine-associated mutants of hepatitis B virus. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo: Springer-Verlag, 1994: 243-247.
25. Masuko K, Mitsui T, Iwano K et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490.
26. Nakatsuji Y, Shih JWK, Tanaka E et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hep 1996; 3: 307-316.
27. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132.
28. Heringer S, Osterkamp S, Trautwein C et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-1629.
29. Tanaka E, Alter HJ, Nakatsuji Y et al. Effect of hepatitis G virus co-infection on patients with chronic hepatitis C. Ann Intern Med 1996; 125: 740-743.
30. Martinot M, Marcellin P, Boyer N et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-α in patients with chronic hepatitis C. Ann Int Med 1997; 126: 874-881.